Keegan BM - Search Results

1

Myelin oligodendrocyte glycoprotein antibodies in pathologically proven multiple sclerosis: frequency, stability and clinicopathologic correlations.

Pittock SJ, Reindl M, Achenbach S, Berger T, Bruck W, Konig F, Morales Y, Lassmann H, Bryant S, Moore SB, Keegan BM, Lucchinetti CF. Pittock SJ, et al. Among authors: keegan bm. Mult Scler. 2007 Jan;13(1):7-16. doi: 10.1177/1352458506072189. Mult Scler. 2007. PMID: 17294606

2

Multiple sclerosis.

Keegan BM, Noseworthy JH. Keegan BM, et al. Annu Rev Med. 2002;53:285-302. doi: 10.1146/annurev.med.53.082901.103909. Annu Rev Med. 2002. PMID: 11818475 Review.

3

A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis.

Wingerchuk DM, Benarroch EE, O'Brien PC, Keegan BM, Lucchinetti CF, Noseworthy JH, Weinshenker BG, Rodriguez M. Wingerchuk DM, et al. Among authors: keegan bm. Neurology. 2005 Apr 12;64(7):1267-9. doi: 10.1212/01.WNL.0000156803.23698.9A. Neurology. 2005. PMID: 15824361 Clinical Trial.

4

Multiple sclerosis, brain radiotherapy, and risk of neurotoxicity: the Mayo Clinic experience.

Miller RC, Lachance DH, Lucchinetti CF, Keegan BM, Gavrilova RH, Brown PD, Weinshenker BG, Rodriguez M. Miller RC, et al. Among authors: keegan bm. Int J Radiat Oncol Biol Phys. 2006 Nov 15;66(4):1178-86. doi: 10.1016/j.ijrobp.2006.06.014. Epub 2006 Sep 11. Int J Radiat Oncol Biol Phys. 2006. PMID: 16965867 Clinical Trial.

5

Sporadic adult-onset leukoencephalopathy with neuroaxonal spheroids mimicking cerebral MS.

Keegan BM, Giannini C, Parisi JE, Lucchinetti CF, Boeve BF, Josephs KA. Keegan BM, et al. Neurology. 2008 Mar 25;70(13 Pt 2):1128-33. doi: 10.1212/01.wnl.0000304045.99153.8f. Epub 2008 Feb 20. Neurology. 2008. PMID: 18287567

6

Autoimmune myelopathy associated with collapsin response-mediator protein-5 immunoglobulin G.

Keegan BM, Pittock SJ, Lennon VA. Keegan BM, et al. Ann Neurol. 2008 Apr;63(4):531-4. doi: 10.1002/ana.21324. Ann Neurol. 2008. PMID: 18306241

7

Multiple sclerosis risk in radiologically uncovered asymptomatic possible inflammatory-demyelinating disease.

Siva A, Saip S, Altintas A, Jacob A, Keegan BM, Kantarci OH. Siva A, et al. Among authors: keegan bm. Mult Scler. 2009 Aug;15(8):918-27. doi: 10.1177/1352458509106214. Mult Scler. 2009. PMID: 19667020

8

Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease.

Magaña SM, Pittock SJ, Lennon VA, Keegan BM, Weinshenker BG, Lucchinetti CF. Magaña SM, et al. Among authors: keegan bm. Arch Neurol. 2009 Aug;66(8):964-6. doi: 10.1001/archneurol.2009.152. Arch Neurol. 2009. PMID: 19667216 Free PMC article.

9

Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients.

Jacob A, Matiello M, Weinshenker BG, Wingerchuk DM, Lucchinetti C, Shuster E, Carter J, Keegan BM, Kantarci OH, Pittock SJ. Jacob A, et al. Among authors: keegan bm. Arch Neurol. 2009 Sep;66(9):1128-33. doi: 10.1001/archneurol.2009.175. Arch Neurol. 2009. PMID: 19752302

10

Multiple sclerosis with predominant, severe cognitive impairment.

Staff NP, Lucchinetti CF, Keegan BM. Staff NP, et al. Among authors: keegan bm. Arch Neurol. 2009 Sep;66(9):1139-43. doi: 10.1001/archneurol.2009.190. Arch Neurol. 2009. PMID: 19752304 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

132 results

Search Page

Filters